Search

Displaying results 6111 - 6120 of 10000 in total
  1. Drug

    ALMB-0168

    go.drugbank.com/drugs/DB16926
    Investigational

    ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.

  2. Drug

    Rotigaptide

    go.drugbank.com/drugs/DB13067
    Investigational

    Rotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.

  3. Drug

    Apabetalone

    go.drugbank.com/drugs/DB12000
    Investigational

    Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.

  4. Drug

    Terameprocol

    go.drugbank.com/drugs/DB12226
    Investigational

    Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

  5. Drug

    Fenamole

    go.drugbank.com/drugs/DB12506
    Investigational

    Fenamole has been investigated for the supportive care of Side Effects and Dental Plaque.

  6. Drug

    Epoetin delta

    go.drugbank.com/drugs/DB11624
    ApprovedWithdrawn

    Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo.

  7. Drug

    Camibirstat

    go.drugbank.com/drugs/DB21586
    Investigational

    Camibirstat is under investigation in clinical trial NCT04891757 (FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies). … Camibirstat has a monoisotopic molecular weight of 562.17 Da.

  8. Drug

    SBT-100

    go.drugbank.com/drugs/DB17215
    Experimental

    SBT-100 is an anti-signal transducer and activator of transcription 3 (STAT3) B VHH13 single-domain antibody (sdAb). … It was granted orphan drug designation by the FDA for the treatment of pancreatic cancer and osteosarcoma.[L44131,L44136]

  9. Drug

    Dansylamide

    go.drugbank.com/drugs/DB02866
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    Otelixizumab

    go.drugbank.com/drugs/DB05496
    Investigational

    Otelixizumab is a monoclonal antibody that binds to a receptor found on all T cells called CD3, which is involved in normal T cell signaling. … Otelixizumab is believed to inhibit the function of autoreactive T cells, which are important in propagating autoimmune diseases, while inducing regulatory T cell pathways that promote immunological tolerance